Published Aug 6, 2026, 3:16 PM ET · Updated 3 months ago · 1 source

Ligand forecasts $9-$9.50 adjusted EPS in 2026 as XOMA deal adds about $0.50 in 2H 2026

Seeking Alpha

Original Report